Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, signaling a site update. The visible study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating an updated page version and likely related internal improvements or bug fixes.
    Difference
    0.1%
    Check dated 2026-09-01T19:15:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This update is a metadata increment and does not change visible content.
    Difference
    0.1%
    Check dated 2026-08-11T19:15:59.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.3 to v3.6.4, signaling a small update to the page's content or formatting.
    Difference
    0.1%
    Check dated 2026-07-28T13:41:45.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3, indicating a minor software update to the page's underlying framework. This change does not indicate any visible alterations to the study details or user-facing content based on the provided data.
    Difference
    0.1%
    Check dated 2026-06-30T02:34:56.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The study page now indicates that enrollment has closed ('No longer looking for participants'). It also adds new sections and headings for user guidance and study details (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment), reflecting a reorganized information layout.
    Difference
    0.4%
    Check dated 2026-06-15T23:56:55.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.